Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30575910 | 1.00 | ERBB2 (0.52) | ERBB2EGFR | |
| SCHEMBL25431089 | 0.92 | ERBB2 (0.55) | ERBB2EGFR | |
| SCHEMBL25431081 | 0.92 | ERBB2 (0.55) | ERBB2EGFR | |
| SCHEMBL29935838 | 0.90 | EGFR (0.56) | ERBB2EGFR | |
| SCHEMBL26005263 | 0.90 | EGFR (0.56) | ERBB2EGFR | |
| SCHEMBL25429663 | 0.89 | EGFR (0.55) | ERBB2EGFR | |
| SCHEMBL25429668 | 0.89 | EGFR (0.55) | ERBB2EGFR | |
| SCHEMBL31541191 | 0.88 | ERBB2 (0.52) | ERBB2EGFR | |
| SCHEMBL30576108 | 0.88 | ERBB2 (0.52) | ERBB2EGFR | |
| SCHEMBL26008871 | 0.88 | ERBB2 (0.52) | ERBB2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023154124-A1 | ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2 | ENLIVEN THERAPEUTICS, INC. (US) | 2023-08-17 | — | — | WO | disclosed |